| Literature DB >> 35546031 |
Matteo Rossini1, Federico Cozzani2, Tommaso Loderer3, Elena Bonati4, Mario Giuffrida5, Paolo Del Rio6.
Abstract
PURPOSE: The aim of this study was firstly to report the experience of intermittent intraoperative neuromonitoring (I-IONM) and evaluate the impact of loss of signal (LOS) in staged thyroidectomy management.Entities:
Mesh:
Year: 2022 PMID: 35546031 PMCID: PMC9171876 DOI: 10.23750/abm.v93i2.11178
Source DB: PubMed Journal: Acta Biomed ISSN: 0392-4203
VHI-10 (Voice Handicap Index-10) questionnaire
| Questions | ||
|---|---|---|
| 1 | My voice makes it difficult for people to hear me | 0 1 2 3 4 |
| 2 | People have difficulty understanding me in a noisy room | 0 1 2 3 4 |
| 3 | My voice difficulties restrict my personal and social life | 0 1 2 3 4 |
| 4 | I feel left out of conversations because of my voice | 0 1 2 3 4 |
| 5 | My voice problem causes me to lose income | 0 1 2 3 4 |
| 6 | People ask, ‘‘What’s wrong with your voice?’’ | 0 1 2 3 4 |
| 7 | I feel as though I have to strain to produce a voice | 0 1 2 3 4 |
| 8 | The clarity of my voice is unpredictable | 0 1 2 3 4 |
| 9 | My voice problem upsets me | 0 1 2 3 4 |
| 10 | My voice makes me feel handicapped | 0 1 2 3 4 |
TAB 1 –Instructions: 0 = never, 1 = almost never, 2 = sometimes, 3 = almost always, 4 = always. Istruzioni: 0 = mai, 1 = quasi mai, 2 = a volte, 3 = quasi sempre, 4 = sempre.
Indications to surgery (MNG – multinodular goiter)
|
|
|
|
|---|---|---|
| Follicular carcinoma | 1 | 0.3% |
| Papillary carcinoma | 129 | 34.2% |
| Medullary carcinoma | 1 | 0.3% |
| MNG | 205 | 54.3% |
| Basedow disease | 25 | 6.6% |
| Other | 16 | 4.3% |
IONM results related to clinical dysphonia occurrence in T1 (evaluation during post-operative hospitalization)
| T1 |
|
|
|---|---|---|
| True Positive | 16 | 2.3% |
| False Positive | 27 | 3.7% |
| True Negative | 670 | 92.5% |
| False Negative | 11 | 1.5% |
IONM results related to clinical dysphonia occurrence in T2 (evaluation at 30 day follow up)
|
|
|
|
|---|---|---|
| True Positive | 11 | 1.5% |
| False Positive | 32 | 4.4% |
| True Negative | 673 | 93% |
| False Negative | 8 | 1.1% |
IONM results related to clinical dysphonia occurrence in T3 (evaluation at 6 months follow up)
|
|
|
|
|---|---|---|
| True Positive | 6 | 0.9% |
| False Positive | 37 | 5.1% |
| True Negative | 680 | 93.9% |
| False Negative | 1 | 0.1% |
VHI-10 score results related to LOS and hystological findings at T1-T2-T3
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| Papillary carcinoma | 5 | 10 | 4 | 8.42±7.42 (1-21) | 6.73±7.1 (1-25) | 3.42±1.12 (1-12) |
| MNG | 8 | 17 | 6 | 12.6±8.5 (2-29) | 10.7±9 (1-30) | 7.1±7.8 (1-30) |
| Basedow | 1 | 2 | 1 | 10±9.4 (2-22) | 7.5±6.45 (2-16) | 2.25±1.25 (1-4) |
TAB 6 – VHI-10 score at T1-T2-T3 has been reported as median ± DS and range.
Statistical results of I-IONM application related to clinical dysphonia occurrence in T1
|
|
|
|
|---|---|---|
| Sensitivity | 59.26% | 38.80%-77.61% |
| Specificity | 96.13% | 94.41%-97.43% |
| Efficiency | 94.75% | 92.87%-96.26% |
| Predictive Value of Positive Test | 37.21% | 22.98%-53.27% |
| Predictive Value of Negative Test | 98.38% | 97.13%-99.19% |
| Likelihood Ratio of Positive Test | 15.297 | 9.4250-24.8296 |
| Likelihood Ratio of Negative Test | 0.4238 | 0.2689-0.6681 |
| Odds ratio | 36.0943 | 15.2940-85.1837 |
Statistical results of I-IONM application related to clinical dysphonia occurrence in T2
|
|
|
|
|---|---|---|
| Sensitivity | 57.89% | 33.50%-79.75% |
| Specificity | 95.46% | 93.65%-96.87% |
| Efficiency | 94.48% | 92.55%-96.02% |
| Predictive Value of Positive Test | 25.58% | 13.52%-41.17% |
| Predictive Value of Negative Test | 98.83% | 97.70%-99.49% |
| Likelihood Ratio of Positive Test | 12.7549 | 7.6478-21.2727 |
| Likelihood Ratio of Negative Test | 0.4411 | 0.2603-0.7475 |
| Odds ratio | 28.9180 | 10.8823-76.8446 |
Statistical results of I-IONM application related to clinical dysphonia occurrence in T3
|
|
|
|
|---|---|---|
| Sensitivity | 85.71% | 42.13%-99.64% |
| Specificity | 94.84% | 92.96%-96.34% |
| Efficiency | 94.75% | 92.87%-96.26% |
| Predictive Value of Positive Test | 13.95% | 5.30%-27.93% |
| Predictive Value of Negative Test | 99.85% | 99.18%-100% |
| Likelihood Ratio of Positive Test | 16.6100 | 10.7424-25.6826 |
| Likelihood Ratio of Negative Test | 0.1506 | 0.0245-0.9247 |
| Odds ratio | 110.2703 | 12.9388-939.1717 |
LOS cases who underwent completion thyroidectomy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Papillary carcinoma | F | 45 | EmiTx | 1 | No | No | Yes | Yes | No | / | 1 | Yes |
| Papillary carcinoma | F | 68 | EmiTx | 2 | Yes | No | No | No | No | / | 2 | Yes |
| Papillary carcinoma | F | 44 | EmiTx | 2 | No | No | No | No | No | / | 2 | Yes |
| Papillary carcinoma | F | 52 | EmiTx | 1 | No | No | No | No | No | / | 2 | Yes |
| Papillary carcinoma | M | 43 | Emitx | 1 | No | No | No | No | No | / | 1 | Yes |
TAB. 10 – (EmiTx – emithyroidectomy, TxTot – Total Thyroidectomy).